Citigroup
IPSC icon

Citigroup’s Century Therapeutics IPSC Stock Holding History

Citigroup’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$140K Buy
+57,001
New +$130K ﹤0.01% 4508
2026
Q1 		– Sell
-1
Closed -$1 – 6155
2025
Q4 		$1 Sell
1
-2,209
-100% -$1.35K ﹤0.01% 5974
2025
Q3 		$1.1K Sell
2,210
-13,763
-86% -$7.42K ﹤0.01% 5612
2025
Q2 		$8.92K Sell
15,973
-16,886
-51% -$9.06K ﹤0.01% 5207
2025
Q1 		$15.6K Sell
32,859
-3,235
-9% -$2.43K ﹤0.01% 5129
2024
Q4 		$36.5K Buy
36,094
+2,007
+6% +$2.73K ﹤0.01% 5164
2024
Q3 		$58.3K Buy
34,087
+23,572
+224% +$46.2K ﹤0.01% 4976
2024
Q2 		$26.8K Buy
10,515
+5,919
+129% +$18.7K ﹤0.01% 4909
2024
Q1 		$19.2K Buy
4,596
+1,078
+31% +$4.56K ﹤0.01% 5040
2023
Q4 		$11.7K Buy
3,518
+2,764
+367% +$5.04K ﹤0.01% 5154
2023
Q3 		$1.51K Sell
754
-7,585
-91% -$20.2K ﹤0.01% 5025
2023
Q2 		$26.4K Buy
8,339
+7,668
+1,143% +$24.7K ﹤0.01% 4888
2023
Q1 		$2.33K Sell
671
-216
-24% -$949 ﹤0.01% 5075
2022
Q4 		$4.55K Sell
887
-120
-12% -$1.13K ﹤0.01% 5053
2022
Q3 		$10K Sell
1,007
-1,165
-54% -$12.3K ﹤0.01% 4991
2022
Q2 		$18K Buy
2,172
+329
+18% +$3.23K ﹤0.01% 5061
2022
Q1 		$23K Sell
1,843
-2,891
-61% -$38.3K ﹤0.01% 5077
2021
Q4 		$75K Buy
4,734
+3,399
+255% +$63.9K ﹤0.01% 4878
2021
Q3 		$34K Buy
+1,335
New +$36.1K ﹤0.01% 4963

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Citigroup's IPSC Position: Q2 2026 in Review

Citigroup opened a new position in Century Therapeutics (IPSC) in Q2 2026: 57,001 shares worth $140K. The stake represents ﹤0.01% of the portfolio and ranks #4508 among its holdings. This is a return to the name: Citigroup previously reported a position in IPSC as recently as Q4 2025.

Citigroup first reported a position in IPSC in Q3 2021 and has held it in 19 quarters since. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Citigroup held 57,001 shares of Century Therapeutics worth $140K as of Q2 2026.
  • Century Therapeutics was a new Citigroup position in Q2 2026.
  • Century Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4508 holding.
  • Citigroup first reported a position in Century Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • 99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.